Update: AstraZeneca Wins FDA Approval For Xigduo XR, Shares Rise
Trevor Lowenthal • Yesterday, 2:14 AM
- AstraZeneca announced today FDA approval for its diabetes combo pill Xigduo XR.
- I reiterate my bull thesis following the approval.
- As expected, AstraZeneca continues to enhance its growth prospects, thus supporting my thesis that it can thrive independent of Pfizer.